Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia

Abstract Background Hyperlipidemia, with an increasing of prevalence, has become one of the common metabolic diseases in companion animal clinic. Aspirin eugenol ester (AEE) is a novel compound that exhibits efficacious anti-hyperlipidemia activities. However, its mechanisms are still not completely...

Full description

Bibliographic Details
Main Authors: Ning Ma, Xi-Wang Liu, Xiao-Jun Kong, Shi-Hong Li, Zeng-Hua Jiao, Zhe Qin, Ya-Jun Yang, Jian-Yong Li
Format: Article
Language:English
Published: BMC 2018-12-01
Series:BMC Veterinary Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12917-018-1711-x
_version_ 1818292422503825408
author Ning Ma
Xi-Wang Liu
Xiao-Jun Kong
Shi-Hong Li
Zeng-Hua Jiao
Zhe Qin
Ya-Jun Yang
Jian-Yong Li
author_facet Ning Ma
Xi-Wang Liu
Xiao-Jun Kong
Shi-Hong Li
Zeng-Hua Jiao
Zhe Qin
Ya-Jun Yang
Jian-Yong Li
author_sort Ning Ma
collection DOAJ
description Abstract Background Hyperlipidemia, with an increasing of prevalence, has become one of the common metabolic diseases in companion animal clinic. Aspirin eugenol ester (AEE) is a novel compound that exhibits efficacious anti-hyperlipidemia activities. However, its mechanisms are still not completely known. The objective of present study was to investigate the intervention effects of AEE on cecal contents metabonomics profile and microbiota in hyperlipidemia rats. Results Three groups of rats were fed with a control diet, or high fat diet (HFD) containing or not AEE. The results showed the beneficial effects of AEE in HFD-fed rats such as the reducing of aspartate aminotransferase (AST) and total cholesterol (TCH). Distinct changes in metabonomics profile of cecal contents were observed among control, model and AEE groups. HFD-induced alterations of eight metabolites in cecal contents mainly related with purine metabolism, linoleic acid metabolism, glycerophospholipid metabolism, sphingolipid metabolism and pyrimidine metabolism were reversed by AEE treatment. Principal coordinate analysis (PCoA) and cluster analysis of microbiota showed altered patterns with distinct differences in AEE group versus model group, indicating that AEE treatment improved the negative effects caused by HFD on cecal microbiota. In addition, the correction analysis revealed the possible link between the identified metabolites and cecal microbiota. Conclusions This study showed regulation effects of AEE on cecal contents metabonomics profile and microbiota, which could provide information to reveal the possible underlying mechanism of AEE on hyperlipidemia treatment.
first_indexed 2024-12-13T02:59:43Z
format Article
id doaj.art-c09c73cfba424e84ace423a3e8406c95
institution Directory Open Access Journal
issn 1746-6148
language English
last_indexed 2024-12-13T02:59:43Z
publishDate 2018-12-01
publisher BMC
record_format Article
series BMC Veterinary Research
spelling doaj.art-c09c73cfba424e84ace423a3e8406c952022-12-22T00:01:52ZengBMCBMC Veterinary Research1746-61482018-12-0114111510.1186/s12917-018-1711-xAspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemiaNing Ma0Xi-Wang Liu1Xiao-Jun Kong2Shi-Hong Li3Zeng-Hua Jiao4Zhe Qin5Ya-Jun Yang6Jian-Yong Li7Key Lab of New Animal Drug Project of Gansu Province; Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural SciencesKey Lab of New Animal Drug Project of Gansu Province; Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural SciencesKey Lab of New Animal Drug Project of Gansu Province; Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural SciencesKey Lab of New Animal Drug Project of Gansu Province; Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural SciencesKey Lab of New Animal Drug Project of Gansu Province; Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural SciencesKey Lab of New Animal Drug Project of Gansu Province; Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural SciencesKey Lab of New Animal Drug Project of Gansu Province; Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural SciencesKey Lab of New Animal Drug Project of Gansu Province; Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural SciencesAbstract Background Hyperlipidemia, with an increasing of prevalence, has become one of the common metabolic diseases in companion animal clinic. Aspirin eugenol ester (AEE) is a novel compound that exhibits efficacious anti-hyperlipidemia activities. However, its mechanisms are still not completely known. The objective of present study was to investigate the intervention effects of AEE on cecal contents metabonomics profile and microbiota in hyperlipidemia rats. Results Three groups of rats were fed with a control diet, or high fat diet (HFD) containing or not AEE. The results showed the beneficial effects of AEE in HFD-fed rats such as the reducing of aspartate aminotransferase (AST) and total cholesterol (TCH). Distinct changes in metabonomics profile of cecal contents were observed among control, model and AEE groups. HFD-induced alterations of eight metabolites in cecal contents mainly related with purine metabolism, linoleic acid metabolism, glycerophospholipid metabolism, sphingolipid metabolism and pyrimidine metabolism were reversed by AEE treatment. Principal coordinate analysis (PCoA) and cluster analysis of microbiota showed altered patterns with distinct differences in AEE group versus model group, indicating that AEE treatment improved the negative effects caused by HFD on cecal microbiota. In addition, the correction analysis revealed the possible link between the identified metabolites and cecal microbiota. Conclusions This study showed regulation effects of AEE on cecal contents metabonomics profile and microbiota, which could provide information to reveal the possible underlying mechanism of AEE on hyperlipidemia treatment.http://link.springer.com/article/10.1186/s12917-018-1711-xAspirin eugenol esterGut microbiotaMetabonomicsCecal contentsHyperlipidemiaUPLC-Q-TOF/MS
spellingShingle Ning Ma
Xi-Wang Liu
Xiao-Jun Kong
Shi-Hong Li
Zeng-Hua Jiao
Zhe Qin
Ya-Jun Yang
Jian-Yong Li
Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia
BMC Veterinary Research
Aspirin eugenol ester
Gut microbiota
Metabonomics
Cecal contents
Hyperlipidemia
UPLC-Q-TOF/MS
title Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia
title_full Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia
title_fullStr Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia
title_full_unstemmed Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia
title_short Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia
title_sort aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia
topic Aspirin eugenol ester
Gut microbiota
Metabonomics
Cecal contents
Hyperlipidemia
UPLC-Q-TOF/MS
url http://link.springer.com/article/10.1186/s12917-018-1711-x
work_keys_str_mv AT ningma aspirineugenolesterregulatescecalcontentsmetabolomicprofileandmicrobiotainananimalmodelofhyperlipidemia
AT xiwangliu aspirineugenolesterregulatescecalcontentsmetabolomicprofileandmicrobiotainananimalmodelofhyperlipidemia
AT xiaojunkong aspirineugenolesterregulatescecalcontentsmetabolomicprofileandmicrobiotainananimalmodelofhyperlipidemia
AT shihongli aspirineugenolesterregulatescecalcontentsmetabolomicprofileandmicrobiotainananimalmodelofhyperlipidemia
AT zenghuajiao aspirineugenolesterregulatescecalcontentsmetabolomicprofileandmicrobiotainananimalmodelofhyperlipidemia
AT zheqin aspirineugenolesterregulatescecalcontentsmetabolomicprofileandmicrobiotainananimalmodelofhyperlipidemia
AT yajunyang aspirineugenolesterregulatescecalcontentsmetabolomicprofileandmicrobiotainananimalmodelofhyperlipidemia
AT jianyongli aspirineugenolesterregulatescecalcontentsmetabolomicprofileandmicrobiotainananimalmodelofhyperlipidemia